Drugs that contain Bortezomib
1. Drug name - BORTEZOMIB
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8962572 | FRESENIUS KABI USA | Bortezomib formulations |
Nov, 2032
(10 years from now) | |
Treatment: NA
Dosage: POWDER;INTRAVENOUS
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 3.5MG/VIAL | POWDER;INTRAVENOUS | Prescription |
2. Drug name - VELCADE
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6958319 | TAKEDA PHARMS USA | Formulation of boronic acid compounds |
Jan, 2022
(8 months ago) | |
| US6713446 | TAKEDA PHARMS USA | Formulation of boronic acid compounds |
Jan, 2022
(8 months ago) | |
| EP2251344A1 | TAKEDA PHARMS USA | Formulation Of Boronic Acid Compounds |
Jan, 2022
(8 months ago) | |
| EP1355910A1 | TAKEDA PHARMS USA | Formulation Of Boronic Acid Compounds |
Jan, 2022
(8 months ago) | |
| EP2251344B1 | TAKEDA PHARMS USA | Formulation Of Boronic Acid Compounds |
Jan, 2022
(8 months ago) | |
| EP1355910B1 | TAKEDA PHARMS USA | Formulation Of Boronic Acid Compounds |
Jan, 2022
(8 months ago) | |
| EP3078667B1 | TAKEDA PHARMS USA | Formulation Of Boronic Acid Compounds |
Jan, 2022
(8 months ago) | |
| EP3078667A1 | TAKEDA PHARMS USA | Formulation Of Boronic Acid Compounds |
Jan, 2022
(8 months ago) | |
Treatment: NA
Dosage: INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 3.5MG/VIAL | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.